Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Oncolytics Bio (ONC.TO)

Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players Newswire.ca - Thu Sep 19, 11:08AM CDT

/CNW/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However,...

ONCY : 0.9500 (+2.15%)
NVS : 116.41 (+0.38%)
LNTH : 108.15 (+0.01%)
STRO : 3.94 (-0.25%)
ZYME : 13.00 (+3.83%)
ONC.TO : 1.32 (+3.13%)
Recent Breakthroughs in Cancer Research Could Impact These Key Companies BayStreet.ca - Thu Sep 19, 10:52AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – In the oncology world, there’s...

ONCY : 0.9500 (+2.15%)
ONC.TO : 1.32 (+3.13%)
NVS : 116.41 (+0.38%)
LNTH : 108.15 (+0.01%)
STRO : 3.94 (-0.25%)
ZYME : 13.00 (+3.83%)
Stocks in play: Oncolytics Biotech Inc Baystreet - Thu Sep 19, 8:27AM CDT

Announced positive clinical results from BRACELET-1, its randomized Phase 2 study evaluating pelareorep ...

ONC.TO : 1.32 (+3.13%)
Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study Newswire.ca - Thu Sep 19, 6:00AM CDT

Overall survival (OS) results from BRACELET-1 corroborate results of previous randomized IND-213 breast cancer study Together, these two studies support the...

ONCY : 0.9500 (+2.15%)
ONC.TO : 1.32 (+3.13%)
Stocks in play: Oncolytics Biotech Inc Baystreet - Fri Sep 6, 8:33AM CDT

Announced that Chief Financial Officer Kirk Look will participate in a fireside chat at the H.C. Wainwright ...

ONC.TO : 1.32 (+3.13%)
Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September Newswire.ca - Fri Sep 6, 7:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 0.9500 (+2.15%)
ONC.TO : 1.32 (+3.13%)
Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates Newswire.ca - Mon Aug 12, 3:37PM CDT

/CNW/ -- USA News Group – Pancreatic cancer is among the deadliest cancers, prompting researchers to focus on early detection to improve survival rates. Johns...

ONCY : 0.9500 (+2.15%)
HALO : 60.04 (-3.64%)
CADL : 7.90 (+1.80%)
MRUS : 50.75 (+2.69%)
RHHBY : 39.4800 (-0.33%)
ONC.TO : 1.32 (+3.13%)
Biotech Innovations Poised to Transform Pancreatic Cancer Treatment and Patient Outcomes BayStreet.ca - Mon Aug 12, 12:44PM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – Pancreatic cancer is among the...

ONCY : 0.9500 (+2.15%)
ONC.TO : 1.32 (+3.13%)
RHHBY : 39.4800 (-0.33%)
HALO : 60.04 (-3.64%)
CADL : 7.90 (+1.80%)
MRUS : 50.75 (+2.69%)
Stocks in play: Oncolytics Biotech® Inc. Baystreet - Fri Aug 2, 11:01AM CDT

Announced that Chief Medical Officer Dr. Thomas Heineman will participate in a fireside chat at Canaccord ...

ONC.TO : 1.32 (+3.13%)
Stocks in play: Oncolytics Biotech Inc Baystreet - Fri Aug 2, 8:22AM CDT

Today announced that Chief Medical Officer Dr. Thomas Heineman will participate in a fireside chat at ...

ONC.TO : 1.32 (+3.13%)

Barchart Exclusives

Madison Square Garden Sports: Yesterday’s Big Sports News Didn’t Attract Unusual Options Activity. It Should. Barchart - 32 minutes ago
Canadian telecom giant Rogers Communications made headlines Wednesday after it acquired BCE’s 37.5% interest in Maple Leaf Sports & Entertainment. Yet, Madison Square Garden Sports’ stock and options weren’t unusually active. They should be. Here’s why. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot